AstraZeneca PLC has signed a partnership with the Oxford University-led group which has emerged as a potential frontrunner in the race to develop a vaccine for COVID-19.
The UK-headquartered company has agreed to oversee global development and distribution of the university’s recombinant adenovirus vaccine candidate, known as...






